New heart drug targeting inflammation falls short in clinical trial

The ZEUS trial fell short, but Novo Nordisk still has high hopes for HERMES and ARTEMIS.

Aug 7, 2026 - 03:00
 0  3
New heart drug targeting inflammation falls short in clinical trial
The ZEUS trial fell short, but Novo Nordisk still has high hopes for HERMES and ARTEMIS.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow